Tsai M L, Chang C C, Lee C L, Huang B Y
Department of Physiology, National Cheng Kung University Medical College, Tainan, Taiwan, ROC.
Chin J Physiol. 2003 Jun 30;46(2):55-62.
A prolonged treatment with 17beta-estradiol reduces the frequency of spontaneous oscillations and the Na+/K+ ATPase activity in rat uteri. Acute inhibition of Na+/K+ ATPase activity by a Na+/K+ ATPase inhibitor, ouabain, decreases the frequency of oxytocin-induced oscillations in uteri. Therefore, the purpose of this study was to examine whether the prolonged inhibition of Na+/K+ ATPase activity by 17beta-estradiol was estrogen receptor (ER)-dependent. The uterine explants from ovariectomized rats were cultured in vitro as our experimental model to compare the effect of two antiestrogenic compounds (ICI 182,780 and tamoxifen) on the Na+/K+ ATPase activity and the frequency of spontaneous oscillations. ATPase assay and a standard muscle bath apparatus were to measure the activity and the contraction. When compared with the control, a 2-day treatment with 17beta-estradiol in vivo or in vitro decreased the activity and the frequency. ICI 182,780 lowered the activity but tamoxifen did not. ICI 182,780 did not decrease the frequency but tamoxifen did. Even the reversal effects of these antiestrogenic compounds on the reduced activity and the frequency by 17beta-estradiol were different. Tamoxifen elicited a greater reversal effect on the reduced activity but ICI 182,780 did not. In contrast, ICI 182,780 elicited a greater reversal effect on the reduced frequency but tamoxifen did not. Prolonged inhibition of Na+/K+ ATPase activity by K+-free solution suppressed the frequency with the elevation of basal tension. Addition of KCl at lower concentrations (0.3-1.2 mM) induced oscillatory contraction after reducing the basal tension. As our data suggest, the prolonged effect of 17beta-estradiol may decrease uterine the activity through ER dependent and independent pathways. The reduction of uterine Na+/K+ ATPase activity by estrogens may increase the basal tension after each oscillatory cycle, which, in part, contributes to the reduced frequency of spontaneous oscillations.
长期用17β-雌二醇治疗可降低大鼠子宫自发振荡的频率以及钠钾ATP酶活性。钠钾ATP酶抑制剂哇巴因对钠钾ATP酶活性的急性抑制作用可降低子宫中催产素诱导的振荡频率。因此,本研究的目的是检验17β-雌二醇对钠钾ATP酶活性的长期抑制是否依赖雌激素受体(ER)。将去卵巢大鼠的子宫外植体进行体外培养作为我们的实验模型,以比较两种抗雌激素化合物(ICI 182,780和他莫昔芬)对钠钾ATP酶活性和自发振荡频率的影响。采用ATP酶测定法和标准肌肉浴装置来测量活性和收缩情况。与对照组相比,体内或体外给予17β-雌二醇进行为期2天的治疗可降低活性和频率。ICI 182,780降低了活性,但他莫昔芬没有。ICI 182,780没有降低频率,但他莫昔芬降低了频率。甚至这些抗雌激素化合物对17β-雌二醇降低的活性和频率的逆转作用也有所不同。他莫昔芬对降低的活性产生了更大的逆转作用,但ICI 182,780没有。相反,ICI 182,780对降低的频率产生了更大的逆转作用,但他莫昔芬没有。无钾溶液对钠钾ATP酶活性的长期抑制作用在基础张力升高的情况下抑制了频率。在较低浓度(0.3 - 1.2 mM)下添加氯化钾在降低基础张力后诱导了振荡性收缩。正如我们的数据所示,17β-雌二醇的长期作用可能通过依赖ER和不依赖ER的途径降低子宫活性。雌激素对子宫钠钾ATP酶活性的降低可能会在每个振荡周期后增加基础张力,这在一定程度上导致了自发振荡频率的降低。